gluconic acid has been researched along with Dermatitis Seborrheica in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chosidow, O; Dreno, B; Moyse, D; Revuz, J | 1 |
Blouin, E; Dréno, B; Moyse, D | 1 |
Ballanger, F; Dréno, B; Khammari, A; Tenaud, I; Volteau, C | 1 |
Alirezai, M; Amblard, P; Auffret, N; Beylot, C; Bodokh, I; Chivot, M; Daniel, F; Dreno, B; Humbert, P; Meynadier, J; Moyse, D; Poli, F | 1 |
2 trial(s) available for gluconic acid and Dermatitis Seborrheica
Article | Year |
---|---|
Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Dermatitis, Seborrheic; Dermatologic Agents; Female; Gluconates; Humans; Ketoconazole; Male; Middle Aged; Treatment Outcome | 2003 |
Multicenter randomized comparative double-blind controlled clinical trial of the safety and efficacy of zinc gluconate versus minocycline hydrochloride in the treatment of inflammatory acne vulgaris.
Topics: Abdominal Pain; Acne Vulgaris; Adolescent; Adult; Anti-Bacterial Agents; Arthralgia; Dermatitis, Seborrheic; Double-Blind Method; Female; Gluconates; Humans; Hypersensitivity; Male; Minocycline; Nausea; Patient Compliance; Patient Dropouts; Patient Satisfaction; Skin; Treatment Outcome; Urticaria; Vomiting; Zinc | 2001 |
2 other study(ies) available for gluconic acid and Dermatitis Seborrheica
Article | Year |
---|---|
[Lithium gluconate 8% in the treatment of seborrheic dermatitis].
Topics: Administration, Topical; Dermatitis, Seborrheic; Gluconates; Humans; Inflammation; Ketoconazole; Lithium Compounds; Ointments | 2007 |
Anti-inflammatory effects of lithium gluconate on keratinocytes: a possible explanation for efficiency in seborrhoeic dermatitis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Cytokines; Dermatitis, Seborrheic; Dermatomycoses; Dose-Response Relationship, Drug; Foreskin; Gluconates; Humans; Infant, Newborn; Keratinocytes; Lithium Compounds; Malassezia; Male; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2008 |